Esmolol in the treatment of coronary heart disease complicated with tachyarrhythmia

Liu pei; Fannannan

您当前的位置：

首页 >

文章列表页 >

Esmolol in the treatment of coronary heart disease complicated with tachyarrhythmia

更新时间：2025-10-15

- Esmolol in the treatment of coronary heart disease complicated with tachyarrhythmia
- Issue 3, Pages: 200-203(2022)
- 作者机构：
  
  河南濮阳广慈医院
- 作者简介：
- 基金信息：
- DOI：
  CLC： R541.4;R541.7
- Published：2022
- 稿件说明：
移动端阅览
Liu pei, Fannannan. Esmolol in the treatment of coronary heart disease complicated with tachyarrhythmia[J]. 2022, (3): 200-203.
DOI：

Liu pei, Fannannan. Esmolol in the treatment of coronary heart disease complicated with tachyarrhythmia[J]. 2022, (3): 200-203. DOI：

摘要

目的探讨艾司洛尔辅助胺碘酮治疗对冠心病合并快速性心律失常患者心电图、心功能的影响。方法选取我院心内科冠心病合并快速性心律失常患者94例，随机分为试验组和对照组，每组47例。对照组给予胺碘酮治疗，试验组给予胺碘酮联合艾司洛尔治疗。比较治疗前及治疗48小时后，两组患者的心功能指标：左室射血分数（LVEF）、心排血量（CO）、左室收缩末期内径（LVESD）、左室舒张末期内径（LVEDD）；动态心电图指标：PR间期、QTc间期、室性期前收缩（PVC）、短阵室性心动过速；心肌标志物水平：肌酸激酶同工酶（CK-MB）、神经末端前体B型利钠肽（NT-pro BNP）的变化；记录两组药物不良反应情况（肝功能异常、低血压、窦性心动过缓）。结果两组患者LVEF、CO均较治疗前显著升高，且试验组明显高于同一时期对照组（p<0.05）；两组LVESD、LVEDD较治疗前明显减少（p<0.05），且试验组明显低于对照组（p<0.05）；两组患者心电图PR间期、QTc间期较治疗前显著延长（p<0.05），且试验组明显长于同一时期对照组（p<0.05）；两组PVC、短阵室性心动过速较治疗前明显减少（p<0.05），且试验组明显少于对照组（p<0.05）；治疗48小时后，两组患者血清CK-MB、NT-pro BNP水平较治疗前显著降低（p<0.05），但差异比较无统计学意义（p>0.05）；试验组药物不良反应总发生率显著低于对照组（p<0.05）。结论艾司洛尔辅助胺碘酮用于冠心病合并快速性心律失常患者具有良好效果，对改善心电图指标及心功能可产生重要作用。

Abstract

Objective To investigate the effect of esmolol assisted amiodarone on ECG and cardiac function in patients with coronary heart disease complicated with rapid arrhythmia. Methods Nity-four patients with coronary heart disease and tachyarrhythmia were randomly divided into experimental group and control group

47 cases in each group. The control group was treated with amiodarone

and the experimental group was treated with amiodarone and esmolol. The cardiac function indexes of the two groups were compared before and after treatment（LVEF）

cardiac output（CO）

left ventricular end systolic diameter（LVESD）

left ventricular end diastolic diameter（LVEDd）

dynamic electrocardiogram index [PR interval

QTc interval

ventricular pre systolic（PVC）

short array ventricular tachycardia] The changes of myocardial marker levels（CK MB）

NT pro BNP in the precursor of nerve terminal were observed; The adverse drug reactions（liver dysfunction

hypotension

sinus heart rate bradycardia） were recorded.Results LVEF and CO in both groups were significantly higher than those before treatment

and the experimental group was significantly higher than that in the control group（p<0.05）

The LVESD and LVEDd in the two groups were significantly lower than that before treatment（p<0.05）

and the experimental group was significantly lower than that of the control group（p<0.05）

The PR interval and QTc interval of ECG in the two groups were significantly longer than that before treatment（p<0.05）

and the experimental group was significantly longer than that of the control group（p<0.05）. The results showed that the PVC and short array ventricular tachycardia in the two groups were significantly lower than that before treatment（p<0.05）

and the experimental group was significantly lower than that of the control group（p<0.05）. After 48 hours of treatment

the serum CK MB and NT pro BNP levels of the two groups were significantly lower than before treatment（p<0.05）

but the difference was not statistically significant（p>0.05）;The total incidence of adverse drug reactions in the experimental group was significantly lower than that of the control group（p<0.05）. Conclusions Esmolol assisted amiodarone has good effect in the patients with coronary heart disease and tachyarrhythmia

which can improve the ECG index and cardiac function.

关键词

Keywords

references

艾司洛尔联合胺碘酮治疗急性心肌梗死合并快速型心律失常患者的疗效及对心电图的影响[J]. 陆远;段洋;李志;陈磊;张敏;王志荣;李承宗.临床内科杂志,2020(11)

艾司洛尔联合低剂量胺碘酮治疗冠心病合并心律失常患者的临床疗效观察[J]. 刘文君;于少娟.岭南心血管病杂志,2019(06)

胺碘酮联合美托洛尔治疗冠心病合并心律失常效果评估[J]. 朱丹桂;陈晶;杜晓马;杨溢.中国药物与临床,2019(21)

艾司洛尔联合胺碘酮治疗老年室性心律失常临床效果与安全性分析[J]. 李宝芸;陈君蓉;王鹏.解放军医药杂志,2019(04)

美托洛尔联合胺碘酮治疗冠心病合并心律失常的临床疗效观察[J]. 王冠男;李勇;张健;张源波.中华老年心脑血管病杂志,2018(09)

急诊应用胺碘酮在治疗冠心病快速心律失常中的效果观察[J]. 吴新杰.临床检验杂志(电子版),2018(03)

胺碘酮治疗冠心病心律失常及其对血流动力学的影响研究[J]. 李敏;李虎;陈海为;朱玉峰;黄金燕;薛旺;欧东波;林尧明;王逵.现代生物医学进展,2018(01)

胺碘酮与艾司洛尔治疗老年患者急性心肌梗死合并室性心律失常的短期疗效与安全性比较[J]. 邹德玲;刘兴利;方悦;陈艳丽;耿宁;庞文跃.药物不良反应杂志,2014(02)

美国和欧洲稳定性冠心病诊治指南解读[J]. 沈迎;张奇;沈卫峰.中华心血管病杂志,2014(01)

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis on the predictive value of ST segment changes and planar QRS-T angle in dynamic electrocardiography for myocardial ischemia of coronary heart disease

Therapeutic effects of transcatheter aortic valve replacement combined with percutaneous coronary intervention and surgical aortic valve replacement combined with coronary artery bypass grafting on patients with aortic stenosis and coronary heart disease

Evaluation and analysis of different ECG modes on myocardial ischemic attack in patients with coronary heart disease

Diagnostic value of synchronous 12 lead Holter combined with coronary CT angiography in coronary heart disease

Application value of modified intrinsic heart rate in the diagnosis of sinoatrial node dysfunction

Related Author

SU Yangang

LIN Chunyao

WANG Huixin

JI Zhanquan

ZHANG Ruicheng

SHI Jingbao

NIU Hongxing

Li huile

Related Institution

Department of Cardiology, Zhongshan Hospital, Fudan University

Department of Electrocardiogram, Zhongshan Hospital, Fudan University (Xiamen Branch)

Department of Cardiac Surgery, Henan Chest Hospital

Department of Cardiothoracic Surgery, Puyang Anyang Regional Hospital

Electrocardiogram department, Xiping hospital of traditional Chinese medicine

⁰